Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody
- PMID: 19497295
- DOI: 10.1016/j.ab.2009.05.043
Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody
Abstract
Despite technological advances, detection of deamidation in large proteins remains a challenge and the use of orthogonal methods is needed for unequivocal assignment. By a combination of cation-exchange separation, papain digestion, and a panel of mass spectrometry techniques we identified asparagine deamidation in light chain complementarity determining region 1 (CDR1) of a humanized IgG1 monoclonal antibody. The reaction yields both Asp and isoAsp, which were assigned by Edman degradation and by isoAsp detection using protein isoaspartate methyltransferase. The deamidated antibody variants were less potent in antigen binding compared to the nondegraded antibody. Changes in near-UV CD spectra, susceptibility to papain cleavage in an adjacent CDR2 loop, and the tendency of the newly formed isoAsp to undergo isomerization suggest local perturbations in the structure of the isoAsp-containing antibody.
Similar articles
-
Aspartate isomerization in the complementarity-determining regions of two closely related monoclonal antibodies.Biochemistry. 2007 Feb 13;46(6):1534-44. doi: 10.1021/bi061500t. Epub 2007 Jan 17. Biochemistry. 2007. PMID: 17279618
-
The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.Arthritis Res Ther. 2005;7(1):R47-56. doi: 10.1186/ar1449. Epub 2004 Nov 16. Arthritis Res Ther. 2005. PMID: 15642142 Free PMC article.
-
In vivo deamidation characterization of monoclonal antibody by LC/MS/MS.Anal Chem. 2005 Mar 1;77(5):1432-9. doi: 10.1021/ac0494174. Anal Chem. 2005. PMID: 15732928
-
Simultaneous assessment of Asp isomerization and Asn deamidation in recombinant antibodies by LC-MS following incubation at elevated temperatures.PLoS One. 2012;7(1):e30295. doi: 10.1371/journal.pone.0030295. Epub 2012 Jan 17. PLoS One. 2012. PMID: 22272329 Free PMC article.
-
Circular dichroism techniques: biomolecular and nanostructural analyses- a review.Chem Biol Drug Des. 2009 Aug;74(2):101-20. doi: 10.1111/j.1747-0285.2009.00847.x. Epub 2009 Jun 29. Chem Biol Drug Des. 2009. PMID: 19566697 Review.
Cited by
-
Comparison of originator and biosimilar therapeutic monoclonal antibodies using comprehensive two-dimensional liquid chromatography coupled with time-of-flight mass spectrometry.MAbs. 2016 Oct;8(7):1224-1234. doi: 10.1080/19420862.2016.1203497. Epub 2016 Jun 30. MAbs. 2016. PMID: 27362833 Free PMC article.
-
Expression and biological characterization of an anti-CD20 biosimilar candidate antibody: a case study.MAbs. 2012 Jul-Aug;4(4):488-96. doi: 10.4161/mabs.20761. Epub 2012 Jul 1. MAbs. 2012. PMID: 22647435 Free PMC article.
-
Biosimilar, biobetter and next generation therapeutic antibodies.MAbs. 2011 Mar-Apr;3(2):107-10. doi: 10.4161/mabs.3.2.14785. Epub 2011 Mar 1. MAbs. 2011. PMID: 21285536 Free PMC article. No abstract available.
-
Cysteinylation of a monoclonal antibody leads to its inactivation.MAbs. 2016 May-Jun;8(4):718-25. doi: 10.1080/19420862.2016.1160179. Epub 2016 Apr 6. MAbs. 2016. PMID: 27050640 Free PMC article.
-
Posttranslational Modifications and the Immunogenicity of Biotherapeutics.J Immunol Res. 2016;2016:5358272. doi: 10.1155/2016/5358272. Epub 2016 Apr 14. J Immunol Res. 2016. PMID: 27191002 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources